Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/spandidos-publications/genetic-profiles-distinguish-different-types-of-hereditary-ovarian-NTPbjVxCZ6
References (47)
-
J. Boyd, Y. Sonoda, M. Federici, F. Bogomolniy, E. Rhei, D. Maresco, P. Saigo, L. Almadrones, R. Barakat, C. Brown, D. Chi, J. Curtin, E. Poynor, W. Hoskins (2000)
Clinicopathologic features of BRCA-linked and sporadic ovarian cancer.JAMA, 283 17
-
S. Malander, M. Ridderheim, A. Måsbäck, N. Loman, U. Kristoffersson, Hampus Olsson, M. Nilbert, Å. Borg (2004)
One in 10 ovarian cancer patients carry germ line BRCA1 or BRCA2 mutations: results of a prospective study in Southern Sweden.European journal of cancer, 40 3
-
H. Lynch, M. Casey, C. Snyder, C. Bewtra, J. Lynch, M. Butts, A. Godwin (2009)
Hereditary ovarian carcinoma: Heterogeneity, molecular genetics, pathology, and managementMolecular Oncology, 3
-
S. Malander, E. Rambech, U. Kristoffersson, Britta Halvarsson, M. Ridderheim, Å. Borg, M. Nilbert (2006)
The contribution of the hereditary nonpolyposis colorectal cancer syndrome to the development of ovarian cancer.Gynecologic oncology, 101 2
-
A. Olshen, E. Venkatraman, R. Lucito, M. Wigler (2004)
Circular binary segmentation for the analysis of array-based DNA copy number data.Biostatistics, 5 4
-
Ofir Israeli, W. Gotlieb, E. Friedman, B. Goldman, G. Ben-Baruch, A. Aviram-Goldring, S. Rienstein (2003)
Familial vs sporadic ovarian tumors: characteristic genomic alterations analyzed by CGH.Gynecologic oncology, 90 3
-
S. Hauptmann, C. Denkert, Ines Koch, S. Petersen, K. Schlüns, A. Reles, M. Dietel, I. Petersen (2002)
Genetic alterations in epithelial ovarian tumors analyzed by comparative genomic hybridization.Human pathology, 33 6
-
M. Moynahan, Tracy Cui, M. Jasin (2001)
Homology-directed dna repair, mitomycin-c resistance, and chromosome stability is restored with correction of a Brca1 mutation.Cancer research, 61 12
-
S. Diskin, T. Eck, J. Greshock, Y. Mossé, Tara Naylor, C. Stoeckert, B. Weber, J. Maris, G. Grant (2006)
STAC: A method for testing the significance of DNA copy number aberrations across multiple array-CGH experiments.Genome research, 16 9
-
P. Schraml, G. Schwerdtfeger, F. Burkhalter, A. Raggi, D. Schmidt, T. Ruffalo, Walter King, K. Wilber, M. Mihatsch, H. Moch (2003)
Combined array comparative genomic hybridization and tissue microarray analysis suggest PAK1 at 11q13.5-q14 as a critical oncogene target in ovarian carcinoma.The American journal of pathology, 163 3
-
Erik Beers, Tibor Welsem, L. Wessels, Yunlei Li, R. Oldenburg, P. Devilee, C. Cornelisse, S. Verhoef, F. Hogervorst, L. Veer, P. Nederlof (2005)
Comparative genomic hybridization profiles in human BRCA1 and BRCA2 breast tumors highlight differential sets of genomic aberrations.Cancer research, 65 3
-
Keren Levanon, C. Crum, R. Drapkin (2008)
New insights into the pathogenesis of serous ovarian cancer and its clinical impact.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 32
-
D. Bell (2005)
Origins and molecular pathology of ovarian cancerModern Pathology, 18
-
R. Schlegel, Gabi, Stumm, Harry, Scherthan, Tina, Bocker, Hubert, Zirngibl, Josef, Rà schoff, Ferdinand, Hofstà (2006)
Advances in Brief Comparative Genomic in Situ Hybridization of Colon Carcinomas with Replication Error ' -
G. Jönsson, J. Staaf, Eleonor Olsson, M. Heidenblad, J. Vallon-Christersson, K. Osoegawa, P. Jong, S. Oredsson, M. Ringnér, M. Höglund, Å. Borg (2007)
High‐resolution genomic profiles of breast cancer cell lines assessed by tiling BAC array comparative genomic hybridizationGenes, 46
-
D. Niederacher, H. Yan, H. An, H. Bender, M. Beckmann (1999)
CDKN2A gene inactivation in epithelial sporadic ovarian cancerBritish Journal of Cancer, 80
-
T. Okuda, J. Otsuka, A. Sekizawa, H. Saito, R. Makino, M. Kushima, A. Farina, Yuzuru Kuwano, T. Okai (2003)
p53 mutations and overexpression affect prognosis of ovarian endometrioid cancer but not clear cell cancer.Gynecologic oncology, 88 3
-
M. Scott, W. Mccluggage (2006)
Current concepts in ovarian epithelial tumorigenesis: correlation between morphological and molecular data.Histology and histopathology, 21 1
-
R. Kurman, I. Shih (2008)
Pathogenesis of Ovarian Cancer: Lessons From Morphology and Molecular Biology and Their Clinical ImplicationsInternational Journal of Gynecological Pathology, 27
-
T. Chan, Lucy Curtis, S. Leung, S. Farrington, J. Ho, Annie Chan, P. Lam, C. Tse, M. Dunlop, A. Wyllie, S. Yuen (2001)
Early-onset colorectal cancer with stable microsatellite DNA and near-diploid chromosomesOncogene, 20
-
A. Saeed, V. Sharov, J. White, J. Li, W. Liang, N. Bhagabati, J. Braisted, M. Kłapa, T. Currier, M. Thiagarajan, A. Sturn, M. Snuffin, A. Rezantsev, D. Popov, A. Ryltsov, E. Kostukovich, I. Borisovsky, Z. Liu, A. Vinsavich, V. Trush, John Quackenbush (2003)
TM4: a free, open-source system for microarray data management and analysis.BioTechniques, 34 2
-
A. Whittemore (1994)
Characteristics relating to ovarian cancer risk: implications for prevention and detection.Gynecologic oncology, 55 3 Pt 2
-
C. Bewtra, P. Watson, T. Conway, Connie Read-Hippee, H. Lynch (1992)
Hereditary Ovarian Cancer: A Clinicopathological StudyInternational Journal of Gynecological Pathology, 11
-
(2008)
Amplification of 11 q 13 in ovarian carcinoma -
(2007)
Normalization of arrayCGH data : influence of copy number imbalances -
Y. Patael-Karasik, M. Daniely, W. Gotlieb, G. Ben-Baruch, J. Schiby, G. Barakai, B. Goldman, A. Aviram, E. Friedman (2000)
Comparative genomic hybridization in inherited and sporadic ovarian tumors in Israel.Cancer genetics and cytogenetics, 121 1
-
Ying Dong, M. Walsh, M. McGuckin, Brian Gabrielli, M. Cummings, R. Wright, T. Hurst, S. Khoo, P. Parsons (1997)
Increased expression of cyclin‐dependent kinase inhibitor 2 (CDKN2A) gene product P16 INK4A in ovarian cancer is associated with progression and unfavourable prognosisInternational Journal of Cancer, 74
-
M. Aarnio, R. Sankila, E. Pukkala, R. Salovaara, L. Aaltonen, A. Chapelle, P. Peltomäki, J. Mecklin, H. Järvinen (1999)
Cancer risk in mutation carriers of DNA‐mismatch‐repair genesInternational Journal of Cancer, 81
-
(2006)
Population brca 1 and BRCA 2 mutation frequencies and cancer penetrances : a kincohort study in Ontario , Canada -
T. Pal, Jennifer Permuth‐Wey, Ambuj Kumar, T. Sellers (2008)
Systematic Review and Meta-analysis of Ovarian Cancers : EstimationofMicrosatellite-High FrequencyandCharacterization ofMismatchRepair -
L. Wessels, Tibor Welsem, A. Hart, L. Veer, M. Reinders, P. Nederlof (2002)
Molecular classification of breast carcinomas by comparative genomic hybridization: a specific somatic genetic profile for BRCA1 tumors.Cancer research, 62 23
-
G. Samimi, D. Fink, N. Varki, A. Husain, W. Hoskins, D. Alberts, S. Howell (2000)
Analysis of MLH 1 and MSH 2 Expression in Ovarian Cancer before and after Platinum Drug-based Chemotherapy 1 -
D. Mayr, A. Hirschmann, U. Löhrs, J. Diebold (2006)
KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants.Gynecologic oncology, 103 3
-
L. Dubeau (2014)
THE CELL OF ORIGIN OF OVARIAN EPITHELIAL TUMORS -
A. Massey, J. Offman, P. Macpherson, P. Karran (2003)
DNA mismatch repair and acquired cisplatin resistance in E. coli and human ovarian carcinoma cells.DNA repair, 2 1
-
P. Møller, A. Hagen, J. Apold, L. Maehle, Neal Clark, B. Fiane, K. Løvslett, E. Hovig, Anita Vabø (2007)
Genetic epidemiology of BRCA mutations--family history detects less than 50% of the mutation carriers.European journal of cancer, 43 11
-
A. Serrano-Olvera, A. Dueñas-González, D. Gallardo-Rincón, M. Candelaria, J. Garza-Salazar (2006)
Prognostic, predictive and therapeutic implications of HER2 in invasive epithelial ovarian cancer.Cancer treatment reviews, 32 3
-
S. Rubin, I. Benjamin, K. Behbakht, Hiroyuki Takahashi, M. Morgan, V. Livolsi, A. Berchuck, M. Muto, J. Garber, Barbara Weber, H. Lynch, J. Boyd (1996)
Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1.The New England journal of medicine, 335 19
-
R. Dehari, R. Kurman, S. Logani, I. Shih (2007)
The Development of High-grade Serous Carcinoma From Atypical Proliferative (Borderline) Serous Tumors and Low-grade Micropapillary Serous Carcinoma: A Morphologic and Molecular Genetic AnalysisThe American Journal of Surgical Pathology, 31
-
L. Saal, C. Troein, J. Vallon-Christersson, Sofia Gruvberger, Å. Borg, C. Peterson (2002)
BioArray Software Environment (BASE): a platform for comprehensive management and analysis of microarray dataGenome Biology, 3
-
P. Watson, R. Bützow, H. Lynch, J. Mecklin, H. Järvinen, H. Vasen, L. Madlensky, P. Fidalgo, I. Bernstein (2001)
The clinical features of ovarian cancer in hereditary nonpolyposis colorectal cancer.Gynecologic oncology, 82 2
-
S. Lakhani, M. Vijver, J. Jacquemier, T. Anderson, P. Osin, L. McGuffog, D. Easton (2002)
The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 20 9
-
G. Jönsson, Tara Naylor, J. Vallon-Christersson, J. Staaf, Jia Huang, M. Ward, M. Stratton, M. Ringnér, A. Borg, Barbara Weber
Distinct Genomic Profiles in Hereditary Breast Tumors Identified by Array-based Comparative Genomic Hybridization -
W. Abdel-Rahman, M. Ollikainen, R. Kariola, H. Järvinen, J. Mecklin, M. Nyström-Lahti, S. Knuutila, P. Peltomäki (2005)
Comprehensive characterization of HNPCC-related colorectal cancers reveals striking molecular features in families with no germline mismatch repair gene mutationsOncogene, 24
-
K. Ratnam, J. Low (2007)
Current Development of Clinical Inhibitors of Poly(ADP-Ribose) Polymerase in OncologyClinical Cancer Research, 13
-
Stephen Cannistra, J. Quinn, C. James, G. Stewart, J. Mulligan, Patricia White, Gary Chang, P. Mullan, P. Johnston, R. Wilson, D. Harkin (2007)
BRCA1 mRNA Expression Levels Predict for Overall Survival in Ovarian Cancer after ChemotherapyClinical Cancer Research, 13
-
A. Jazaeri, C. Yee, C. Sotiriou, Kelly Brantley, J. Boyd, E. Liu (2002)
Gene expression profiles of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers.Journal of the National Cancer Institute, 94 13
- Publisher
- Spandidos Publications
- Copyright
- Copyright © Spandidos Publications
- ISSN
- 1021-335X
- eISSN
- 1791-2431
- DOI
- 10.3892/or_00000934
- Publisher site
- See Article on Publisher Site
Abstract
Heredity represents the strongest risk factor for ovarian cancer with disease predisposing mutations identified in 15% of the tumors. With the aim to identify genetic classifiers for hereditary ovarian cancer, we profiled hereditary ovarian cancers linked to the hereditary breast and ovarian cancer (HBOC) syndrome and the hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Genome-wide array comparative genomic hybridization was applied to 12 HBOC associated tumors with BRCA1 mutations and 8 HNPCC associated tumors with mismatch repair gene mutations with 24 sporadic ovarian cancers as a control group. Unsupervised cluster analysis identified two distinct subgroups related to genetic complexity. Sporadic and HBOC associated tumors had complex genetic profiles with an average 41% of the genome altered, whereas the mismatch repair defective tumors had stable genetic profiles, with an average 18% of the genome altered. Losses of 4q34, 13q12-q32 and 19p13 were overrepresented in the HBOC subset. Discriminating genes within these regions include BRCA2, FOXO1A and RB1. Gains on chromosomes 17 and 19 characterized the HNPCC tumors, but target genes herein are unknown. The results indicate that HBOC and HNPCC associated ovarian cancer develop along distinct genetic pathways and genetic profiles can thus be applied to distinguish between different types of hereditary ovarian cancer.
Journal
Oncology Reports – Spandidos Publications
Published: Oct 1, 2010